Modified Process Hepatitis B Vaccine (V232-062)

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Modified Process Hepatitis B Vaccine (V232-062), covering 2014-02-17 to 2014-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062) [Phase 3]